Brand Value Zicam is an established OTC cold and allergy relief brand that has attracted attention from major outlets and was acquired by Church & Dwight for a significant sum, indicating strong market potential and credibility for B2B partnerships or co-branding opportunities.

Acquisition Upsell Post-acquisition growth potential could be unlocked through distribution extensions, private label opportunities, or cross-sell of Zicam products within Church & Dwight’s expansive retail network and existing customer base.

Market Leadership Recognition as the #1 Pharmacist Recommended Brand and #1 zinc supplement in the VMS cough/cold segment signals strong consumer trust; potential asks include wholesale placements, pharmacy-focused programs, and targeted in-store promotions.

Small Scale With a lean team and revenue under one million, there is a clear opportunity to offer scalable manufacturing, co-packing, or distribution services to support growth without the complexities of larger incumbents.

Tech & Compliance Adoption of cloud-based tech and security layers (Azure, Cloudflare, reCAPTCHA) suggests receptiveness to modern e-commerce, digital marketing partnerships, and data-driven insights for optimized retail campaigns and fraud prevention.